Tower Research Capital »

Allogene Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $27k 6.1k 4.47
2023-09-30 $26k 8.2k 3.17
2023-06-30 $68k 14k 4.97
2023-03-31 $42k 8.4k 4.98
2022-12-31 $143k 17k 8.70
2022-09-30 $295k 27k 10.80
2022-06-30 $246k 18k 13.33
2022-03-31 $243k 27k 9.13
2021-12-31 $223k 15k 15.03
2021-09-30 $316k 12k 25.64
2021-06-30 $162k 6.2k 26.00
2021-03-31 $182k 5.2k 35.32
2020-12-31 $133k 5.3k 25.16
2020-09-30 $130k 3.4k 37.80
2020-06-30 $556k 13k 42.81
2020-03-31 $1.0k 64 15.63
2019-12-31 $110k 4.2k 26.09
2019-09-30 $78k 2.9k 27.03
2019-06-30 $2.0k 74 27.03